• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
MeiraGTx released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 410K (forecast USD 6.966M), actual EPS USD -0.624 (forecast USD -0.49)
04:00
MeiraGTx released FY2025 9 Months Earnings on November 13 (EST), with actual revenue of USD 6.027 M and EPS of USD -1.6113
04:00
Nov13
MeiraGTx Reports Q3 Revenue Below Estimates
13:01
Nov10
MeiraGTx Updates Late-Stage Clinical Pipeline and Manufacturing Capabilities
12:34
MeiraGTx Holdings plc and Eli Lilly Enter into Strategic Collaboration in Ophthalmic Gene Therapy
12:01
Aug15
MeiraGTx released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 3.691 M (forecast USD 6.484 M), actual EPS USD -0.4814 (forecast USD -0.4675)
03:00

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 410 K, Net Income -50.51 M, EPS -0.624

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.691 M, Net Income -38.8 M, EPS -0.4814

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.926 M, Net Income -39.98 M, EPS -0.5058

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More